Lack of transparency? Infant formula trial review sparks debate on industry’s role

Formula companies are emphasizing the importance of research integrity and independence

Related Articles

FormattedPicture

BUSINESS NEWS

This week in nutrition news, DSM secured approval in Canada for the use of its human-identical milk oligosaccharide (HMO) GlyCare 2’-fucosyllactose (2FL) in infant... Read More

FormattedPicture

BUSINESS NEWS

At the SupplySide West trade show in Las Vegas, US, Arla Foods Ingredients spotlighted whey protein and electrolytes, stressing that the combination of these core... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

Arla Foods Ingredients has formed a partnership with British dairy cooperative First Milk to produce a specialist whey protein powder – Nutrilac FO-7875 – at... Read More

FormattedPicture

BUSINESS NEWS

Perrigo has acquired Nestlé’s gateway infant formula plant in Wisconsin, US, and purchased US and Canadian rights to the Nestlé-owned Good Start... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Arla Foods Ingredients is introducing the Refreshing Fermented Protein drink within the healthy beverage space. The new solution, based on 100% whey-based hydrolysates... Read More

trans